全文获取类型
收费全文 | 5598篇 |
免费 | 482篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 256篇 |
妇产科学 | 121篇 |
基础医学 | 672篇 |
口腔科学 | 131篇 |
临床医学 | 607篇 |
内科学 | 1292篇 |
皮肤病学 | 48篇 |
神经病学 | 353篇 |
特种医学 | 582篇 |
外科学 | 456篇 |
综合类 | 194篇 |
一般理论 | 8篇 |
预防医学 | 531篇 |
眼科学 | 51篇 |
药学 | 401篇 |
中国医学 | 11篇 |
肿瘤学 | 356篇 |
出版年
2021年 | 76篇 |
2020年 | 55篇 |
2019年 | 72篇 |
2018年 | 90篇 |
2017年 | 51篇 |
2016年 | 69篇 |
2015年 | 88篇 |
2014年 | 114篇 |
2013年 | 194篇 |
2012年 | 195篇 |
2011年 | 235篇 |
2010年 | 159篇 |
2009年 | 153篇 |
2008年 | 201篇 |
2007年 | 227篇 |
2006年 | 226篇 |
2005年 | 224篇 |
2004年 | 209篇 |
2003年 | 183篇 |
2002年 | 221篇 |
2001年 | 161篇 |
2000年 | 160篇 |
1999年 | 152篇 |
1998年 | 178篇 |
1997年 | 165篇 |
1996年 | 158篇 |
1995年 | 136篇 |
1994年 | 101篇 |
1993年 | 101篇 |
1992年 | 89篇 |
1991年 | 111篇 |
1990年 | 66篇 |
1989年 | 137篇 |
1988年 | 124篇 |
1987年 | 135篇 |
1986年 | 103篇 |
1985年 | 114篇 |
1984年 | 74篇 |
1983年 | 63篇 |
1982年 | 60篇 |
1981年 | 38篇 |
1980年 | 54篇 |
1979年 | 55篇 |
1978年 | 38篇 |
1977年 | 39篇 |
1976年 | 41篇 |
1975年 | 49篇 |
1973年 | 42篇 |
1972年 | 30篇 |
1971年 | 31篇 |
排序方式: 共有6106条查询结果,搜索用时 15 毫秒
1.
2.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献3.
Gerald T Voelbel Marsha E Bates Jennifer F Buckman Gahan Pandina Robert L Hendren 《Neuropsychopharmacology》2006,60(9):942-950
BACKGROUND: Impaired neuropsychological test performance, especially on tests of executive function and attention, is often seen in children diagnosed with autism spectrum disorders (ASD). Structures involved in fronto-striatal circuitry, such as the caudate nucleus, may support these cognitive abilities. However, few studies have examined caudate volumes specifically in children with ASD, or correlated caudate volumes to cognitive ability. METHODS: Neuropsychological test scores and caudate volumes of children with ASD were compared to those of children with bipolar disorder (BD) and of typically developing (TD) children. The relationship between test performance and caudate volumes was analyzed. RESULTS: The ASD group displayed larger right and left caudate volumes, and modest executive deficits, compared to TD controls. While caudate volume inversely predicted performance on the Wisconsin Card Sorting Test in all participants, it differentially predicted performance on measures of attention across the ASD, BD and TD groups. CONCLUSIONS: Larger caudate volumes were related to impaired problem solving. On a test of attention, larger left caudate volumes predicted increased impulsivity and more omission errors in the ASD group as compared to the TD group, however smaller volume predicted poorer discriminant responding as compared to the BD group. 相似文献
4.
5.
6.
D V Bates 《Canadian Medical Association journal》1991,144(5):554-556
7.
8.
Alan Willmore Tim Sladden Lucy Bates Craig B Dalton 《International journal of health geographics》2006,5(1):30-14
Background
To determine patterns of childhood lead exposure in a community living near a lead and zinc smelter in North Lake Macquarie, Australia between 1991 and 2002. 相似文献9.
10.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献